FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to gynecology and reproductive medicine. What is presented is a method for assessing endometrial receptivity in a secretion phase in women with primary infertility caused by endometrial hyperplasia. When examining endometrial specimens obtained by the method of pipelle biopsy on 20–22 days of the menstrual cycle, progesterone and PTEN expression in glands and stroma and number of CD20+ cells in stroma are determined, then prognostic index (PI) is calculated by formula PI=X1×-0.48+X2×-1.5+X3×-23.07+0.87×X4+X5×-1.21+592. If PI is less than 0, high risk of reproductive failures is predicted. If PI is more than 0, a high probability of pregnancy is stated.
EFFECT: invention provides assessing endometrial receptivity in primary infertility caused by endometrial hyperplasia.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ASSESSING ENDOMETRIAL RECEPTIVITY IN FEMALES WITH PRIMARY INFERTILITY AND UTERINE MYOMA | 2020 |
|
RU2732430C1 |
METHOD FOR EVALUATING ENDOMETRIAL DYSFUNCTION IN FEMALES WITH PRIMARY ENDOMETRIOSIS-ASSOCIATED INFERTILITY | 2020 |
|
RU2732432C1 |
METHOD FOR EVALUATING RECEPTIVITY OF ENDOMETRIUM IN SECRETORY PHASE IN WOMEN WITH PRIMARY INFERTILITY CAUSED BY ENDOMETRIAL HYPOPLASIA | 2020 |
|
RU2731203C1 |
METHOD FOR PREDICTING IMPLANTATION AND CHILDBIRTH IN ART PROGRAMS IN WOMEN OF OLDER REPRODUCTIVE AGE WITH TUBOPERITONEAL INFERTILITY FACTOR BASED ON THE LEVEL OF ENDOMETRIAL EXPRESSION OF HOXA11 | 2021 |
|
RU2770288C1 |
METHOD FOR ASSESSING ENDOMETRIAL RECEPTIVENESS IN ENDOMETRIOSIS-ASSOCIATED INFERTILITY | 2020 |
|
RU2724381C1 |
METHOD FOR ASSESSMENT OF ENDOMETRIAL IMPLANTATION CONSISTENCY IN PROLIFERATIVE-INFLAMMATORY DISORDERS IN ENDOMETRIUM IN ENDOMETRIOSIS ASSOCIATED WITH ENDOMETRIAL FACTOR OF INFERTILITY | 2020 |
|
RU2724384C1 |
METHOD FOR EVALUATING THE RECEPTIVITY OF THE ENDOMETRIUM DURING THE “IMPLANTATION WINDOW” | 2017 |
|
RU2651762C1 |
METHOD FOR ENDOMETRIAL IMPLANTATION POTENTIAL EVALUATION IN ENDOMETRIOSIS-ASSOCIATED INFERTILITY | 2020 |
|
RU2734840C1 |
METHOD FOR ASSESSING THE IMPLANTATION VIABILITY OF ENDOMETRIUM IN REPEATED IMPLANTATION FAILURES ASSOCIATED WITH CHRONIC ENDOMETRITIS | 2021 |
|
RU2746644C1 |
METHOD OF DETERMINING PERSONAL "IMPLANTATION WINDOW" IN WOMEN BASED ON ANALYSIS OF TRANSCRYPTION PROFILE OF GENES | 2016 |
|
RU2636527C1 |
Authors
Dates
2020-09-16—Published
2020-03-31—Filed